In addition to PC, IST5 has been shown to have remarkable efficacy in chronic myeloid leukemia (CML) cells which is another Stat5-driven cancer [10]. This evidence concerns the gene STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive.